Evidence map›Paper›PMID 31948487›Full record

ArticleAddiction science & clinical practice2020

Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.

Gavin B Bart, Andrew Saxon, David A Fiellin, Jennifer McNeely, John P Muench, Christopher W Shanahan, Kristen Huntley, Robert E Gore-Langton

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Redesign of Opioid Use Disorder Screening and Treatment in the ED.NEJM catalyst innovations in care delivery · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 1 country.

Gavin B BartDivision of Addiction Medicine, Hennepin Healthcare, University of Minnesota, 701 Park Avenue, Minneapolis, MN, 55415, USA. bartx005@umn.edu.ORCID 0000-0001-6127-8530
Andrew SaxonDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA.
David A FiellinDepartment of Medicine, Program in Addiction Medicine, Yale University School of Medicine, E.S. Harkness Building A, 367 Cedar Street, Suite 406A, New Haven, CT, 06510, USA.
Jennifer McNeelyDepartment of Population Health, Section on Tobacco, Alcohol, and Drug Use, NYU School of Medicine, 180 Madison Ave., New York, NY, 10016, USA.
John P MuenchDepartment of Family Medicine, Oregon Health & Science University, 3930 SE Division Street, Portland, OR, 97202, USA.
Christopher W ShanahanSection of General Internal Medicine, Boston University School of Medicine, Crosstown Center, 801 Massachusetts Avenue, Boston, MA, 02118, USA.
Kristen HuntleyCenter for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
Robert E Gore-LangtonThe Emmes Company, Rockville, MD, USA.
Boston University · USEmmes (United States) · USNational Institutes of Health · USNew York University · USOregon Health & Science University · USUniversity of Minnesota · USUniversity of Washington · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Suicide Prediction and Prevention for People at Risk for Opioid Use DisorderUG1DA040316 · NIDA · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI GAVIN BART · 2015 to 2026
$42.2M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS 5UG1DA040316NIDA NIH HHS HHSN271201400028CNIDA NIH HHS HHSN271201500070CNIDA NIH HHS UG1 DA040316
6 · The paper itself

Abstract

There is an urgent need for strategies to address the US epidemic of prescription opioid, heroin and fentanyl-related overdoses, misuse, addiction, and diversion. Evidence-based treatment such as medications for opioid use disorder (MOUD) are available but lack numbers of providers offering these services to meet the demands. Availability of electronic health record (EHR) systems has greatly increased and led to innovative quality improvement initiatives but this has not yet been optimized to address the opioid epidemic or to treat opioid use disorder (OUD). This report from a clinical decision support (CDS) working group convened by the NIDA Center for the Clinical Trials Network aims to converge electronic technology in the EHR with the urgent need to improve screening, identification, and treatment of OUD in primary care settings through the development of a CDS algorithm that could be implemented as a tool in the EHR. This aim is consistent with federal, state and local government and private sector efforts to improve access and quality of MOUD treatment for OUD, existing clinical quality and HEDIS measures for OUD or drug and alcohol use disorders, and with a recent draft grade B recommendation from the US Preventative Services Task Force (USPSTF) for screening for illicit drug use in adults when appropriate diagnosis, treatment and care services can be offered or referred. Through a face-to-face expert panel meeting and multiple follow-up conference calls, the working group drafted CDS algorithms for clinical care felt to be essential for screening, diagnosis, and management of OUD in primary care. The CDS algorithm was reviewed by addiction specialists and primary care providers and revised based on their input. A clinical decision support tool for OUD screening, assessment, and treatment within primary care systems may help improve healthcare delivery to help address the current epidemic of opioid misuse and overdose that has outpaced the capacity of specialized treatment settings. A semi-structured outline of clinical decision support for OUD was developed to facilitate implementation within the EHR. Further work for adaptation at specific sites and for testing is needed.

Indexed as

AlgorithmsDecision Support Systems, ClinicalElectronic Health RecordsHealth Services AccessibilityHumansMass ScreeningNational Institute on Drug Abuse (U.S.)Opiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareUnited StatesAddictionClinical decision support (CDS)DrugEpidemicMedications for opioid use disorder (MOUD)Opioid use disorder (OUD)OverdosePrescription

Identifiers

PMID31948487
PMCPMC6966783
OpenAlexW3006066894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.